Based on the region, the global biologics market report covers the growth opportunities and recent trends across North America, Europe, the Asia Pacific (APAC), & the Middle East & Africa. Among these, North America will dominate the market over the forecast period. Increasing cancer and diabetic population, government support for R&D, increasing healthcare expenditure, systematic drug review process, and rising technological advances in healthcare are adding to the global biologics market share growth in the region. Germany and the UK have a maximum share in the region.